Moderna, Inc. vs Teucrium Wheat Fund — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Teucrium Wheat Fund trades at $25.21. The key difference: Teucrium Wheat Fund is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | WEAT | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $81.80 | $25.49 |
52-Week Low | $22.36 | $19.88 |
Enterprise Value | $19.70B | — |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →